NCT02419235

Brief Summary

Refractory hypertension is defined as failure to reach goal blood pressure control in patients who are adherent to full doses of the appropriate drug regime. Hypertension results in 7.6 million deaths annually and 92 million disability adjusted years worldwide, making it the number one attributable risk for death throughout the world. Conventional treatment involves lifestyle modification and antihypertensive drug therapy; however blood pressure can remain uncontrolled despite these treatment options. Previous studies have demonstrated a reduction in blood pressure in adults with essential hypertension with the use of various homoeopathic complexes. There has been no research done to date on the effect of the homoeopathic combination of Amylenum nitrosum 6cH, Crataegus oxyacantha 6cH, Natrum muriaticum 6cH and Scutellaria lateriflora 6cH in adults with refractory hypertension. The aim of the study is to investigate the effect of a homoeopathic complex Amylenum nitrosum 6cH, Crataegus oxyacantha 6cH, Natrum muriaticum 6cH and Scutellaria lateriflora 6cH on blood pressure in adults with refractory hypertension, by means of blood pressure readings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Oct 2014

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 4, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 17, 2015

Completed
Last Updated

May 17, 2016

Status Verified

May 1, 2016

Enrollment Period

5 months

First QC Date

April 4, 2015

Last Update Submit

May 16, 2016

Conditions

Keywords

Refractory hypertensionHomoeopathyHomoeopathic complexAmylenum nitrosum 6cHCrataegus oxyacantha 6cHNatrum muriaticum 6cHScutellaria lateriflora 6cH

Outcome Measures

Primary Outcomes (1)

  • Weekly blood pressure measurements using a Dura Shock Handheld Aneroid sphygmomanometer model DS55

    Blood pressure will be monitored in the left and right arm of each participant with a Dura Shock Handheld Aneroid sphygmomanometer model DS55, which will be correctly calibrated. An obese BP cuff will be used for overweight participants to ensure reliable results. Blood pressure measurements will be conducted according to standard operating procedures.

    6 weeks

Study Arms (2)

20% Ethanol

PLACEBO COMPARATOR

Ten drops of unmedicated 20% ethanol must be administered under the tongue, three times per day, thirty minutes before or after meals, for six weeks.

Other: 20% ethanol

Homoeopathic complex

EXPERIMENTAL

Ten drops of 20% ethanol medicated with Amylenum nitrosum 6cH, Crataegus oxyacantha 6cH, Natrum muriaticum 6cH and Scutellaria lateriflora 6cH will be administered under the tongue, three times per day, thirty minutes before or after meals, for six weeks.

Other: Homoeopathic complex

Interventions

Unmedicated 20% ethanol.

Also known as: 20% alcohol
20% Ethanol

20% ethanol medicated with Amylenum nitrosum 6cH, Crataegus oxyacantha 6cH, Natrium muriaticum 6cH and Scutellaria lateriflora 6cH.

Homoeopathic complex

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Are male or female, between the ages of 35-60 years;
  • have a systolic blood pressure between 140 mmHg-160 mmHg;
  • have a diastolic blood pressure between 90 mmHg-99 mmHg; and
  • are on 3 or more conventional anti-hypertensive medications of different drug classes, one of which must be a diuretic.

You may not qualify if:

  • Have a systolic blood pressure \< 140 mmHg; \> 160 mmHg;
  • have a diastolic blood pressure \< 90 mmHg; \> 99 mmHg;
  • are pregnant or lactating;
  • are on any other herbal or homoeopathic medicine for the treatment of hypertension;
  • have secondary organ damage from hypertension; and or
  • suffer from chronic conditions such as severe cardiac disease, renal failure, malignant hypertension or diabetes mellitus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Johannesburg

Johannesburg, Gauteng, 2028, South Africa

Location

MeSH Terms

Conditions

Essential HypertensionHypertension

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Janice Pellow, M.TechHom

    University of Johannesburg

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr J. Pellow

Study Record Dates

First Submitted

April 4, 2015

First Posted

April 17, 2015

Study Start

October 1, 2014

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

May 17, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

Locations